Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FGMAC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,893
Award facts
- Contract value 100% obligated
- $6,892.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,892.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections on October 28, 2025. This non-competitive, firm fixed-price delivery order was issued under DLA's larger Pharmaceutical Prime Vendor Global Program contract vehicle, designated SPE2DX, which carries an indefinite delivery contract ceiling of $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, the company's corporate headquarters, with an ultimate completion date of October 29, 2025. Mounjaro is a once-weekly injectable medication used for glycemic control in type 2 diabetes, reflecting DLA's ongoing procurement of specialty pharmaceutical products to support military and veteran healthcare systems.
This delivery order represents a routine transactional award under AmerisourceBergen Drug Corp's existing IDC with DLA Troop Support Medical, one of the company's significant federal contract vehicles. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded prime contract demonstrates the company's established capability to meet federal medical procurement requirements and fulfill the critical role of pharmaceutical supplier within DLA's global medical supply chain serving military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB26FGMAC?
SPE2DB26FGMAC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FGMAC worth?
The government has obligated $6,893 on SPE2DB26FGMAC.
Is contract SPE2DB26FGMAC an order under another contract?
Yes. SPE2DB26FGMAC is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGMAC competed?
The extent of competition for SPE2DB26FGMAC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award